...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZEN003694 Trial is now recruiting patients

A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer

ClincalTrials.gov site for this trial was updated yesterday to change the status from "Not yet recruiting" to "Recruiting"

Share
New Message
Please login to post a reply